Job Description
Market Access Associate Director will be responsible for all aspects of the pricing and reimbursement process in Mexico, including but not limited to independently leading and coordinating cross functional projects, project manager the preparation of reimbursement dossiers in cooperation with Distributor partner. Negotiation with payer, response to payer questions; price management and business cases for new launch approvals and/or price changes for Mexico.
Key Responsibilities:
-
This position will develop market access materials (Price and Reimbursement submission in Mexico, responses, price analysis) for Vertex medicines leading up to and during their launch.
-
Ensure optimized listing at National Compendium (Mexican General Health Council) for innovative Vertex products in any of Vertex’ disease areas of interest
-
Ensure listing at major Public Institutions (IMSS, IMSS-Bienestar, ISSSTE, PEMEX, SEDENA, SEMAR, SSA / INSAHE institutions, other) for Vertex products
-
Ensure reimbursement for Vertex therapies by local private insurance companies
-
Equip commercial team with locally relevant economic value messages. Drive internal and external trainings on HE value-proposition for Vertex therapies
-
Support proactive monitoring of health policy & reimbursement policy changes in Mexico (public and private)
-
This position will lead the development of solid business cases per country/product for obtaining internal senior leadership approval.
-
This position will create innovative offers and access programs. Prepare and lead payer negotiation in close collaboration with country commercial lead and market access distributors lead.
-
This position will ensure pricing compliance in assigned territory, manage country prices and analytics, and maintain updated Pricing Systems. In addition will be responsible for collecting local market insights, rules, and regulations.
-
The position will work closely with Vertex’s Commercial, finance, medical, legal, marketing and market access international teams, building and leveraging relationships with relevant stakeholders in line with Vertex’s approved and agreed business strategy.
-
Exhibit ownership and accountability for all projects and internal assignments.
-
Exemplify Vertex’s core values in fulfilling these job duties.
Required Education Level
-
Masters or bachelor’s degree in a science/analytic field or healthcare professional.
-
Extensive experience within health economic arena.
Required Experience
-
Strong experience in launching rare disease portfolio leading Market Access hands on activities in Mexico.
-
Sound understanding of healthcare system, reimbursement system and P&R submissions in Mexico.
-
Excellent negotiation skills with Payors.
Required Knowledge/Skills
-
Ability to think strategically and make sound pricing and market access insights/recommendations
-
The ideal candidate should be highly motivated, detail-oriented, and organized
-
Strong team player with excellent interpersonal, communication, and presentation skills to communicate complex concepts and negotiate with others
-
Strong record of successful negotiations with payers
-
Ability to complete projects and achieve goals on time while delivering high quality results.
-
Strong analytical skills with proven ability to effectively analyze data sets to determine trends and inform strategies
-
Fluent in English and Spanish.
Other Requirements
• Ability to travel up to 30% within Mexico and Internationally when required.
Please note, only CVs/ Resumes in English will be reviewed. All candidates at all stages will be interviewed in English.
Flex Designation:
Hybrid-Eligible Or On-Site Eligible
Flex Eligibility Status:
In this Hybrid-Eligible role, you can choose to be designated as:
1. Hybrid: work remotely up to two days per week; or select
2. On-Site: work five days per week on-site with ad hoc flexibility.
Note: The Flex status for this position is subject to Vertex’s Policy on Flex @ Vertex Program and may be changed at any time.
Company Information
Vertex is a global biotechnology company that invests in scientific innovation.
Vertex is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, sex, gender identity or expression, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, sexual orientation, marital status, or any characteristic protected under applicable law. Vertex is an E-Verify Employer in the United States. Vertex will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Any applicant requiring an accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied should make a request to the recruiter or hiring manager, or contact Talent Acquisition at [email protected]
What We Do
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases.
We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 3,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development.
Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the French Prix Galien and the British Pharmacological Society awards.
